The natural history of chronic widespread pain in patients with axial spondyloarthritis: a cohort study with clinical and self-tracking data

Author:

Soni Anushka1ORCID,Nishtala Revathi2ORCID,Ng Stanley3,Barnett Rosemarie4ORCID,Chyou Te-yuan5,Cavill Charlotte6ORCID,Sengupta Raj6ORCID

Affiliation:

1. Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre , Oxford, UK

2. Leeds School of Medicine, University of Leeds , Leeds, UK

3. White Swan Charity , Exeter, UK

4. Department for Health, University of Bath , Bath, UK

5. Department of Biochemistry, University of Otago , Dunedin, New Zealand

6. Department of Rheumatology, Royal National Hospital for Rheumatic Diseases , Bath, UK

Abstract

Abstract Objectives This study investigates longitudinal patterns, predictors and long-term impact of pain in axial spondyloarthritis (axSpA), using clinical and self-tracking data. Methods The presence of multisite pain (MSP), affecting at least six of nine body regions using a Margolis pain drawing, and subsequent chronic widespread pain (CWP), MSP at more than one timepoint, was assessed in a cohort of axSpA patients. Incident MSP (MSP at two consecutive visits or more), intermittent MSP (MSP at two or more non-consecutive visits) and persistent MSP (MSP at each visit) were described. Demographic, clinical and self-tracking measures were compared for the CWP vs non-CWP groups using Students t test, Wilcoxon–Mann–Whitney and χ2 test for normal, non-normal and categorical data, respectively. Predictors of CWP were evaluated using logistic regression modelling. Results A total of 136 patients, mean clinical study duration of 120 weeks (range 27–277 weeks) were included, with sufficient self-tracking data in 97 patients. Sixty-eight (50%) patients reported MSP during at least one clinical visit: eight (6%) incident MSP; 16 (12%) persistent MSP; and 44 (32%) intermittent MSP. Forty-six (34%) of the cohort had CWP. All baseline measures of disease activity, function, quality of life, sleep disturbance, fatigue and overall activity impairment were significant predictors of the development of CWP. BASDAI and BASFI scores were significantly higher in those with CWP and self-tracking data revealed significantly worse pain, fatigue, sleep quality and stress. Conclusions The development of CWP is predicted by higher levels of disease activity and burden at baseline. It also impacts future disease activity and wellbeing.

Funder

UCB

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference48 articles.

1. How to use the new American College of Rheumatology fibromyalgia diagnostic criteria;Wolfe;Arthritis Care Res,2011

2. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria;Wolfe;Semin Arthritis Rheum,2016

3. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity;Wolfe;Arthritis Care Res,2010

4. Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage;Almodovar;Clin Exp Rheumatol,2010

5. Occurrence of fibromyalgia in patients with ankylosing spondylitis;Azevedo;Rev Bras Reumatol,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3